Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by jfm1330on Oct 30, 2020 1:53pm
93 Views
Post# 31813958

RE:RE:RE:RE:RE:RE:Stepped up their Corporate Presentation Game

RE:RE:RE:RE:RE:RE:Stepped up their Corporate Presentation GameI agree it is a better presentation, but I still doubt that this is as important as some think here. We did not learn anything really new in it. You will tell me that it is not every investor that is following the company as closely as we do here, and that now there is an easy to consult document summarazing all the key points about the company. Yes, it's true. But who will go to Thera's website and read it and understand it? Also, I don't think such documents makes a difference for big investors, funds, stuff like that. They have people to do the research on stocks. So basically, this presentation is there to help individual investors interested enough to go to the company's website and search for it, then read it, and understand it enough to be convinced to buy the stock. Call me crazy, but I think I understand this company quite well, and I am still waiting to buy back for general market reasons. Maybe I am wrong and I will miss the train, but I still fear the stock will go lower with a correction in the general market.

I think that what Thera needs is a cascade effect or a domino effect. They need one big investing move from somebody. They need some external validation that will trigger a larger investing  movement. They need something that will signal that it is time to jump in. Despite two approved drugs and two very promising programs, I don't feel this urgency to buy right now. That being said, that does not mean it is not the right time to buy. As I said, maybe I will miss a great opportunity by waiting like I do now.
<< Previous
Bullboard Posts
Next >>